Standout Papers

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis 2005 2026 2012 2019 2.9k
  1. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis (2005)
    Paul Rutgeerts, William J. Sandborn et al. New England Journal of Medicine
  2. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD (2021)
    Dan Turner, Amanda Ricciuto et al. Gastroenterology
  3. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis (2017)
    William J. Sandborn, Chinyu Su et al. New England Journal of Medicine
  4. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial (2015)
    Paul Moayyedi, Michael G. Surette et al. Gastroenterology
  5. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis (2011)
    William J. Sandborn, Gert Van Assche et al. Gastroenterology
  6. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial (2016)
    Julián Panés, Damián García‐Olmo et al. The Lancet
  7. Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis (2011)
    Jean‐Frédéric Colombel, Paul Rutgeerts et al. Gastroenterology
  8. Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis (2013)
    William J. Sandborn, Brian G. Feagan et al. Gastroenterology
  9. Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial (2012)
    Paul Rutgeerts, Gert Van Assche et al. Gastroenterology
  10. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry (2020)
    Erica J. Brenner, Ryan C. Ungaro et al. Gastroenterology
  11. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) (2011)
    Simon Travis, Dan Schnell et al. Gut
  12. Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study (2022)
    William J. Sandborn, Geert D’Haens et al. Gastroenterology

Immediate Impact

8 from Science/Nature 240 standout
Sub-graph 1 of 10

Citing Papers

Crohn's disease
2024 Standout
Ulcerative Colitis in Adults
2023 Standout
230 intermediate papers

Works of Walter Reinisch being referenced

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
2011 Standout
and 71 more

Author Peers

Author Last Decade Papers Cites
Walter Reinisch 13684 10707 5093 334 19.2k
Anne M. Griffiths 15754 11072 7093 361 22.4k
Antoine Cortot 11509 8183 5930 274 19.0k
Simon Travis 14524 11373 7291 419 21.1k
Stephen B. Hanauer 18615 14207 6145 398 24.1k
Laurent Beaugerie 10855 8471 5097 293 17.6k
Julián Panés 13720 10880 8255 570 25.1k
David T. Rubin 10620 8224 4945 709 17.3k
Marc Ferrante 12056 8679 5160 517 20.6k
Stephan R. Targan 17995 12274 5869 428 30.4k
Lloyd Mayer 9267 6730 3929 183 18.8k

All Works

Loading papers...

Rankless by CCL
2026